Skip to main content

Ipsilateral invasive cancer risk after diagnosis with ductal carcinoma in situ in patients with and without index surgery: The effects of endocrine therapy and radiation treatment

Publication ,  Conference
Ryser, MD; Rushing, CN; Thomas, SM; Lynch, T; McCarthy, A; Mohammed, ZA; Francescatti, AB; Frank, ES; Partridge, AH; Thompson, AM; Hyslop, T ...
Published in: CANCER RESEARCH
2021

Duke Scholars

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2021

Volume

81

Issue

4

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ryser, M. D., Rushing, C. N., Thomas, S. M., Lynch, T., McCarthy, A., Mohammed, Z. A., … Hwang, E. S. (2021). Ipsilateral invasive cancer risk after diagnosis with ductal carcinoma in situ in patients with and without index surgery: The effects of endocrine therapy and radiation treatment. In CANCER RESEARCH (Vol. 81).
Ryser, Marc D., Christel N. Rushing, Samantha M. Thomas, Thomas Lynch, Anne McCarthy, Zahed A. Mohammed, Amanda B. Francescatti, et al. “Ipsilateral invasive cancer risk after diagnosis with ductal carcinoma in situ in patients with and without index surgery: The effects of endocrine therapy and radiation treatment.” In CANCER RESEARCH, Vol. 81, 2021.
Ryser MD, Rushing CN, Thomas SM, Lynch T, McCarthy A, Mohammed ZA, Francescatti AB, Frank ES, Partridge AH, Thompson AM, Hyslop T, Hwang ES. Ipsilateral invasive cancer risk after diagnosis with ductal carcinoma in situ in patients with and without index surgery: The effects of endocrine therapy and radiation treatment. CANCER RESEARCH. 2021.

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2021

Volume

81

Issue

4

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis